Northwest Biotherapeutics reported $31.1M in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Agenus AGEN:US USD 429.02M 27.15M
AstraZeneca AZN:LN USD 94.18B 2.39B
Bristol Myers Squibb BMY:US USD 98.2B 2.16B
Celldex Therapeutics CLDX:US USD 369.23M 33.74M
Cti Biopharma CTIC:US USD 123.47M 11.07M
Cytori Therapeutics CYTX:US USD 23.1M 1.83M
Cytrx CYTR:US USD 6.56M 2.16M
Eisai 4523:JP JPY 1.26T 11.59B
Infinity Pharmaceuticals INFI:US USD 51.59M 10.27M
Mirati Therapeutics MRTX:US USD 1.3B 23.29M
Northwest Biotherapeutics NWBO:US USD 31.1M 3.58M
Roche Holding ROG:VX 86.74B 5.58B